Warren R, Reich K, Simpson E, Langley R, Costanzo A, Saeki H, Almgren P, Vacko E, Carlsson A, Gooderham M, Deleuran M, Silvestre JF, Weidinger S, Blauvelt A. 3 years of tralokinumab treatment provides long term disease control as demonstrated by clinically meaningful outcomes in modera te to severe atopic dermatitis. J of Skin [Internet]. 2023Mar.13 [cited 2024Jul.22];7(2):s142. Available from: https://jofskin.org/index.php/skin/article/view/2028